Breaking News Instant updates and real-time market news.

KURA

Kura Oncology

$21.05

-0.4 (-1.86%)

16:21
08/06/18
08/06
16:21
08/06/18
16:21

Kura Oncology reports Q2 EPS (45c), consensus (44c)

Cash, cash equivalents and short-term investments totaled $125.9M as of June 30, compared with $93.1M as of December 31, 2017.

  • 06

    Aug

  • 07

    Aug

  • 14

    Aug

  • 14

    Aug

KURA Kura Oncology
$21.05

-0.4 (-1.86%)

02/16/18
SBSH
02/16/18
NO CHANGE
Target $28
SBSH
Buy
Kura Oncology price target raised to $28 from $19 at Citi
Citi analyst Joel Beatty raised his price target for Kura Oncology to $28 citing increased confidence that Tipifarnib is a differentiated therapy for the treatment of HRAS mutant head and neck squamous cell cancer. The analyst sees a 55% probability of success. It is more probable than not that the five of eight, or 63% response rate observed thus far in head and neck squamous cell cancer is a "real efficacy signal," and the duration of response in this indication reinforces this view, Beatty tells investors in a research note. The analyst keeps a Buy rating on Kura Oncology.
02/16/18
OPCO
02/16/18
NO CHANGE
Target $30
OPCO
Outperform
Kura Oncology price target raised to $30 from $17.50 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Kura Oncology to $30 citing the positive updated preliminary results from the company's Phase II study of tipifarnib in patients with HRAS mutant head and neck squamous cell carcinoma. The analyst increased her estimated revenue in 2020-2022 by 66.7% per year. She keeps an Outperform rating on Kura Oncology.
07/09/18
OPCO
07/09/18
NO CHANGE
Target $35
OPCO
Outperform
Kura Oncology price target raised to $35 from $27 at Oppenheimer
Oppenheimer analyst Leah Rush Cann raised her price target for Kura Oncology to $35 from $27, citing an increased average forward price-to-sales multiple of the biotechnology sector. The analyst reiterates an Outperform rating on the shares.
08/01/18
HCWC
08/01/18
INITIATION
Target $31
HCWC
Buy
Kura Oncology initiated with a Buy at H.C. Wainwright
H.C. Wainwright analyst Joseph Pantginis started Kura Oncology with a Buy rating and $31 price target. The shares currently do not reflect the overall opportunity for tipifarnib, which is about to enter a pivotal program in head and neck squamous cell carcinoma patients as well as several other indications, which could lead to a broad label for the drug, Pantginis tells investors in a research note.

TODAY'S FREE FLY STORIES

SBUX

Starbucks

$77.07

0.65 (0.85%)

06:10
04/26/19
04/26
06:10
04/26/19
06:10
Recommendations
Starbucks analyst commentary  »

Starbucks price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MOGO

Mogo Finance

$3.40

0.14 (4.29%)

06:09
04/26/19
04/26
06:09
04/26/19
06:09
Conference/Events
Mogo Finance management to meet with B. Riley FBR »

Meeting to be held in Los…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

VLEEY

Valeo

$0.00

(0.00%)

06:09
04/26/19
04/26
06:09
04/26/19
06:09
Downgrade
Valeo rating change  »

Valeo downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$146.64

-6.455 (-4.22%)

06:09
04/26/19
04/26
06:09
04/26/19
06:09
Earnings
Lear backs FY19 revenue view $20.9B-$21.7B, consensus $21.3B »

Backs FY19 adjusted…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 16

    May

ZBH

Zimmer Biomet

$124.78

0.31 (0.25%)

06:09
04/26/19
04/26
06:09
04/26/19
06:09
Earnings
Zimmer Biomet reports Q1 adj. EPS $1.87, consensus $1.86 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 10

    May

SPSC

SPS Commerce

$102.41

0.16 (0.16%)

06:08
04/26/19
04/26
06:08
04/26/19
06:08
Upgrade
SPS Commerce rating change  »

SPS Commerce upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    May

  • 07

    May

  • 14

    May

  • 28

    May

  • 05

    Jun

ESXB

Community Bankers Trust

$7.33

-0.01 (-0.14%)

06:08
04/26/19
04/26
06:08
04/26/19
06:08
Earnings
Community Bankers Trust reports Q1 EPS 16c, consensus 14c »

Reports Q1 BASEL III CET1…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 17

    May

FDX

FedEx

$188.80

-9.03 (-4.56%)

06:07
04/26/19
04/26
06:07
04/26/19
06:07
Downgrade
FedEx rating change  »

FedEx downgraded to Sell…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 30

    Apr

  • 01

    May

  • 07

    May

  • 03

    Jun

  • 25

    Jun

  • 13

    Nov

MTN

Vail Resorts

$217.30

0.95 (0.44%)

06:07
04/26/19
04/26
06:07
04/26/19
06:07
Initiation
Vail Resorts initiated  »

Vail Resorts initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

LEA

Lear

$146.64

-6.455 (-4.22%)

06:07
04/26/19
04/26
06:07
04/26/19
06:07
Earnings
Lear reports Q1 adj. EPS $4.00, consensus $4.11 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 08

    May

  • 16

    May

MMYT

MakeMyTrip

$26.38

0.52 (2.01%)

, CTRP

Ctrip

$42.51

-0.44 (-1.02%)

06:06
04/26/19
04/26
06:06
04/26/19
06:06
Hot Stocks
MakeMyTrip's shareholding changing between Naspers and Ctrip »

MakeMyTrip (MMYT)…

MMYT

MakeMyTrip

$26.38

0.52 (2.01%)

CTRP

Ctrip

$42.51

-0.44 (-1.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MAS

Masco

$37.50

-2.48 (-6.20%)

06:06
04/26/19
04/26
06:06
04/26/19
06:06
Upgrade
Masco rating change  »

Masco upgraded to Strong…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 10

    May

SFLY

Shutterfly

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Upgrade
Shutterfly rating change  »

Shutterfly upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

SORL

SORL Auto Parts

$3.89

0.17 (4.57%)

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Hot Stocks
SORL Auto Parts receives 'going private' proposal for $4.26 per share »

SORL Auto Parts announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PATK

Patrick Industries

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Downgrade
Patrick Industries rating change  »

Patrick Industries…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

SAH

Sonic Automotive

$17.83

1.99 (12.56%)

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Upgrade
Sonic Automotive rating change  »

Sonic Automotive upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PFPT

Proofpoint

$131.35

3.56 (2.79%)

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Recommendations
Proofpoint analyst commentary at Piper Jaffray »

Proofpoint price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 13

    Nov

INTC

Intel

$57.59

-1.13 (-1.92%)

, QCOM

Qualcomm

$85.07

-1.76 (-2.03%)

06:05
04/26/19
04/26
06:05
04/26/19
06:05
Periodicals
Intel CEO to WSJ: Apple, Qualcomm settlement pushed it to exit mobile 5G »

Intel (INTC) CEO Bob Swan…

INTC

Intel

$57.59

-1.13 (-1.92%)

QCOM

Qualcomm

$85.07

-1.76 (-2.03%)

AAPL

Apple

$205.28

-1.82 (-0.88%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Apr

  • 01

    May

  • 08

    May

  • 16

    May

  • 03

    Jun

  • 03

    Jun

SFLY

Shutterfly

$42.30

-0.65 (-1.51%)

06:04
04/26/19
04/26
06:04
04/26/19
06:04
Upgrade
Shutterfly rating change  »

Shutterfly upgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 15

    May

AON

Aon plc

$179.61

1.32 (0.74%)

06:04
04/26/19
04/26
06:04
04/26/19
06:04
Earnings
Aon plc reports Q1 adj. EPS $3.31 , consensus $3.31 »

Reports Q1 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 07

    May

  • 20

    May

  • 11

    Jun

CVEO

Civeo

$2.19

-0.07 (-3.10%)

06:03
04/26/19
04/26
06:03
04/26/19
06:03
Earnings
Civeo sees FY19 revenue $475M-$485M, consensus $481.8M »

Sees FY19 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 16

    May

CLF

Cleveland-Cliffs

$9.71

0.19 (2.00%)

06:03
04/26/19
04/26
06:03
04/26/19
06:03
Upgrade
Cleveland-Cliffs rating change  »

Cleveland-Cliffs upgraded…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MMM

3M

$190.67

-28.57 (-13.03%)

06:03
04/26/19
04/26
06:03
04/26/19
06:03
Downgrade
3M rating change at BofA/Merrill »

3M downgraded to Neutral…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 14

    May

  • 18

    May

  • 29

    May

CVEO

Civeo

$2.19

-0.07 (-3.10%)

06:02
04/26/19
04/26
06:02
04/26/19
06:02
Earnings
Civeo sees Q2 revenue $113M-$118M, consensus $117.2M »

Sees Q2 adjusted EBITDA…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Apr

  • 16

    May

TWTR

Twitter

$38.48

-0.8 (-2.04%)

06:01
04/26/19
04/26
06:01
04/26/19
06:01
Periodicals
Twitter CEO Dorsey called Rep. Omar over Trump's tweet, Washington Post says »

Twitter CEO Jack Dorsey…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    May

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.